Streetbeat News

Price Targets

CAKE

Cheesecake Factory (NASDAQ:CAKE) has been rated by 11 analysts in the past three months, with a shift towards a more bearish sentiment. The average 12-month price target is now $31.45, down 7.5% from previous estimates. Analysts from firms like Wedbush, Piper Sandler, Barclays, Stephens & Co., Deutsche Bank, Citigroup, Morgan Stanley, and B of A Securities have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Cheesecake Factory's financial indicators show a mixed performance with strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

MMSI

Merit Medical Systems (NASDAQ:MMSI) has received varied analyst ratings over the past three months, with 3 bullish and 1 somewhat bullish out of 4 total ratings. The average 12-month price target is $93.25, with a high of $100.00 and a low of $81.00, reflecting a 4.78% increase from the previous target of $89.00. Analysts from Canaccord Genuity, Barrington Research, and Needham have updated their ratings and price targets, indicating a positive outlook on the company's performance. Merit Medical Systems specializes in medical equipment for interventional procedures and has shown strong financial indicators such as revenue growth, net margin, ROE, ROA, and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

NVRO

Nevro (NYSE:NVRO) has received mixed analyst ratings over the last three months, with 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target is now $19.00, down from $22.12. Analysts from Canaccord Genuity, RBC Capital, Truist Securities, JP Morgan, Piper Sandler, and Morgan Stanley have adjusted their ratings and price targets. Nevro's financials show a revenue growth of 3.38%, a net margin of -22.61%, an ROE of -8.09%, an ROA of -4.15%, and a debt-to-equity ratio of 0.68.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

CMG

Wedbush analyst Nick Setyan has downgraded Chipotle Mexican Grill (NYSE:CMG) from Outperform to Neutral, while setting a price target of $2400 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 1:55 pm

BB

BlackBerry Ltd (NYSE:BB) shares dropped after reporting Q3 financial results with revenue of $175 million, slightly above estimates, but projecting Q4 revenue below expectations. The company reported a smaller loss per share compared to last year and highlighted strong cybersecurity deals. Analyst Luke Junk from Baird maintained a Neutral rating on BB but lowered the price target from $5.50 to $5.

Portfolio Pulse from Adam Eckert

December 21, 2023 | 1:46 pm

CLNN

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Clene Inc. (NASDAQ:CLNN) and maintained a price target of $7. The reaffirmation of the Buy rating and price target suggests continued confidence in the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 1:34 pm

MMSI

Canaccord Genuity analyst Jon Young has upgraded Merit Medical Systems (NASDAQ:MMSI) from Hold to Buy and increased the price target from $76 to $100.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 1:19 pm

SPG

Simon Property Group (NYSE:SPG) has received mixed ratings from 4 analysts in the past three months, with an average 12-month price target of $143.25, up from the previous $136.00. Analysts from Morgan Stanley, Piper Sandler, Truist Securities, and Stifel have adjusted their ratings and price targets, reflecting their views on the company's market conditions and performance. Simon Property Group is a major REIT with a diverse portfolio and has shown strong financial health indicators such as revenue growth, net margin, ROE, and ROA, but carries a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 1:01 pm

HIW

Highwoods Properties (NYSE:HIW), a REIT focused on urban properties in the Southern US, has seen a shift in analyst sentiment over the past three months, with 4 analysts providing ratings. The average 12-month price target has decreased to $22.5 from $29.25, with individual targets ranging from $18 to $28. Analysts from Morgan Stanley, Truist Securities, B of A Securities, and Mizuho have all lowered their price targets. Despite the lowered targets, Highwoods Props has shown strong financial performance with a revenue growth rate of 0.05%, a net margin of 10.67%, an ROE of 0.91%, and an ROA of 0.37%, although it has a high debt-to-equity ratio of 1.33.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 1:01 pm

LLY

Eli Lilly (NYSE:LLY) has received diverse opinions from 14 analysts over the past quarter, with 3 bullish, 10 somewhat bullish, and 1 indifferent. The average 12-month price target is $643.21, with a high of $722.00 and a low of $535.00, marking a 4.93% increase from the previous average of $613.00. Analysts from firms like Daiwa Capital, Truist Securities, and Morgan Stanley have maintained or raised their ratings and price targets. Eli Lilly, a drug firm focusing on various therapeutic areas, has shown a revenue growth rate of 36.84% as of September 30, 2023, but has below-average net margin, ROE, and ROA, and a high debt-to-equity ratio of 1.8.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 1:00 pm